Nuclear Industry’s response to COVID-19 outbreak

Journal of Nuclear Energy Science & Power Generation Technology is pleased to announce Special issue on “Nuclear Industry’s response to COVID-19 outbreak”.

Amidst the global COVID-19 pandemic, nuclear medicine is having its time to shine. Nuclear medicine, which relies on the use of radioactive drugs or radiopharmaceuticals (RPs) for either diagnostic or therapeutic purpose, has rapidly become a crucial medical field. Nuclear-derived techniques, such as RT-PCR, are important tools in the rapid detection and characterization of viruses, like the one causing COVID-19.

Nuclear Medicine has played a key role in diagnosing and treating a variety of diseases, including cancer, heart, lung and kidney conditions as well as infectious diseases by injecting a radiolabeled molecule as a biomarker and thus nuclear-assisted tests can be used to detect the novel coronavirus and track its transmission paths.

With the same purpose our Journal “Journal of Nuclear Energy Science & Power Generation Technology” is announcing Special issue Call for paper on “Nuclear Industry’s response to COVID-19 outbreak”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.

Submission Process 

  • Special issue articles can include both original unpublished research articles and review articles related to the specific theme

  • Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.

  • All the articles in special issues should strictly adhere to journal style and formatting.

  • Each special issue can be created with 5-7 articles.

  • All accepted manuscripts can be submitted online via or through an email id to

  • Submission should be accompanied by a cover letter with reference to the concerned special issue theme.

Please visit Instruction for authors page to know more about article formatting and guidelines:

Track Your Manuscript

Media Partners